Loading...
Market
Outcome of vaccine safety concerns for pregnancy by end of 2024?
2
Resolution / Starting Odds
Revised guidelines • 25%
Increased studies • 25%
No change • 25%
Other actions • 25%
Official health organization announcements and policy changes
Story
Family of Pregnant Woman Who Died Post-AstraZeneca Vaccine to Receive Over R$ 1 Million
Dec 7, 2024, 02:29 PM
The family of Thais Possati, a 35-year-old woman who was 23 weeks pregnant when she died shortly after receiving the AstraZeneca Covid-19 vaccine in April 2021, will receive over R$ 1 million in compensation. AstraZeneca has admitted that the vaccine was not tested on pregnant women. This case has raised concerns about the safety of vaccines for pregnant individuals, especially as the CDC recently recommended a novel Hepatitis B vaccine during pregnancy despite limited studies on its effects, including a retrospective cohort study of 75 women and a rat study.
View original story
Similar markets
No changes recommended • 25%
Some vaccines recommended for elimination • 25%
Enhanced safety protocols recommended • 25%
Comprehensive overhaul of vaccine policies • 25%
No issues found • 25%
Minor issues found • 25%
Significant issues found • 25%
Undetermined • 25%
Vaccines deemed safe • 25%
Vaccines require modification • 25%
Vaccines deemed unsafe • 25%
No consensus reached • 25%
Confirms higher SAE rate in early batches • 25%
Confirms no difference in SAE rates • 25%
Finds other contributing factors • 25%
Inconclusive results • 25%
Increased trust • 25%
Decreased trust • 25%
No significant change • 25%
Mixed responses • 25%
Increased confidence • 25%
Decreased confidence • 25%
No change • 25%
Mixed opinions • 25%
No change in safety guidelines • 25%
Minor safety warning issued • 25%
Major safety warning issued • 25%
Vaccine approval revoked • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
CDC • 25%
WHO • 25%
Both • 25%
Neither • 25%
